Cognitive resilience and improvements in health-related quality of life over 4 years in people with relapsing multiple sclerosis treated with cladribine tablets: Results from the CLARIFY-MS Extension study
Cognitive resilience and improvements in health-related quality of life over 4 years in people with relapsing multiple sclerosis treated with cladribine tablets: Results from the CLARIFY-MS Extension study. // Multiple Sclerosis and Related Disorders. – URL: https://www.sciencedirect.com/science/article/pii/S2211034826009648?dgcid=rss_sd_all
Cognitive resilience and improvements in health-related quality of life over 4 years in people with relapsing multiple sclerosis treated with cladribine tablets: Results from the CLARIFY-MS Extension study. Multiple Sclerosis and Related Disorders. https://www.sciencedirect.com/science/article/pii/S2211034826009648?dgcid=rss_sd_all
“Cognitive resilience and improvements in health-related quality of life over 4 years in people with relapsing multiple sclerosis treated with cladribine tablets: Results from the CLARIFY-MS Extension study.” Multiple Sclerosis and Related Disorders.
@article{article9280,
title = {Cognitive resilience and improvements in health-related quality of life over 4 years in people with relapsing multiple sclerosis treated with cladribine tablets: Results from the CLARIFY-MS Extension study},
journal = {Multiple Sclerosis and Related Disorders},
url = {https://www.sciencedirect.com/science/article/pii/S2211034826009648?dgcid=rss_sd_all}
}